http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
1 online resource (xvi, 383 pages, 8 unnumbered pages of plates) : illustrations (some color)
For some time immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs considerable refinement. Whilst some programmes are looking to increase the understanding of molecular and cellular mechanisms underlying the stimulation of antitumor immunity, others are trying to find the most appropriate clinical setting that will reveal the role of the immune system in combating cancer. Among the most important discoveries have been tumor-specific antigens. This thematic volume highlights some key issues.
Cancer immunosurveillance and immunoediting / Mark J. Smyth, Gavin P. Dunn, and Robert D. Schreiber -- Mechanisms of immune evasion by tumors / Charles G. Drake, Elizabeth Jaffee, and Drew M. Pardoll -- Development of antibodies and chimeric molecules for cancer immunotherapy / Thomas A. Waldmann and John C. Morris -- Industion of tumor immunity following allogeneic stem cell transplatnation / Catherine J. Wu and Jerome Ritz -- Vaccination for treatment and prevention of cancer in animal models / Federica Cavallo [and others] -- Unraveling the complex relationship between cancer immunity and autoimmunity / Hiroshi Uchi [and others] -- Immunity to melanoma antigens / Craig L. Slingluff [and others] -- Checkpoint blackade in cancer immunotherapy / Alan J. Kroman, Karl S. Peggs, and James P. Allison -- Combinatorial cancer immunotherapy / F. Stephen Hodi and Glenn Dranoff.
edited by James P. Allison, Glenn Dranoff ; series editor, Frederick W. Alt.
Includes bibliographical references and index.
Amsterdam ; Boston : Elsevier Academic Press, ©2006